Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guido Plotz

Showing results (21-30 of 49) with videos related to

Pageof 5
Sort By:
Plos One|January 9, 2014
Promoter methylation of MLH1, PMS2, MSH2 and p16 is a phenomenon of advanced-stage HCCsInga Hinrichsen, Matthias Kemp, Jan Peveling-Oberhag, et al.
The Journal of Molecular Diagnostics : JMD|December 28, 2019
Validation of an in Vitro Mismatch Repair Assay Used in the Functional Characterization of Mismatch Repair VariantsMaribel González-Acosta, Inga Hinrichsen, Anna Fernández, et al.
Cancers|March 25, 2022
High Expression of Casein Kinase 2 Alpha Is Responsible for Enhanced Phosphorylation of DNA Mismatch Repair Protein MLH1 and Increased Tumor Mutation Rates in Colorectal CancerKatharina Ulreich, May-Britt Firnau, Nina Tagscherer, et al.
Molecular Carcinogenesis|February 23, 2017
Loss of MLH1 sensitizes colon cancer cells to DNA-PKcs inhibitor KU60648Inga Hinrichsen, Anne Ackermann, Tonja Düding, et al.
Human Mutation|April 5, 2012
MUTYH gene expression and alternative splicing in controls and polyposis patientsGuido Plotz, Markus Casper, Jochen Raedle, et al.
Cancers|July 24, 2021
SPTAN1 Expression Predicts Treatment and Survival Outcomes in Colorectal CancerChristopher Schrecker, Sophia Behrens, Rebecca Schönherr, et al.
Molecular Carcinogenesis|August 3, 2017
Phosphorylation-dependent signaling controls degradation of DNA mismatch repair protein PMS2Inga Hinrichsen, Isabel M Weßbecher, Meik Huhn, et al.
Gastroenterology|January 10, 2002
Functional analysis of hMLH1 variants and HNPCC-related mutations using a human expression systemJoerg Trojan, Stefan Zeuzem, Ann Randolph, et al.
Cancer|July 15, 2005
BRAF mutations in colorectal carcinoma suggest two entities of microsatellite-unstable tumorsNikolaus Lubomierski, Guido Plotz, Marc Wormek, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 4, 2009
An interstitial deletion at 3p21.3 results in the genetic fusion of MLH1 and ITGA9 in a Lynch syndrome familyClaus Meyer, Angela Brieger, Guido Plotz, et al.
Pageof 5

Showing results (21-30 of 49) with videos related to

Sort By:
Pageof 5
Plos One|January 9, 2014
Promoter methylation of MLH1, PMS2, MSH2 and p16 is a phenomenon of advanced-stage HCCsInga Hinrichsen, Matthias Kemp, Jan Peveling-Oberhag, et al.
The Journal of Molecular Diagnostics : JMD|December 28, 2019
Validation of an in Vitro Mismatch Repair Assay Used in the Functional Characterization of Mismatch Repair VariantsMaribel González-Acosta, Inga Hinrichsen, Anna Fernández, et al.
Cancers|March 25, 2022
High Expression of Casein Kinase 2 Alpha Is Responsible for Enhanced Phosphorylation of DNA Mismatch Repair Protein MLH1 and Increased Tumor Mutation Rates in Colorectal CancerKatharina Ulreich, May-Britt Firnau, Nina Tagscherer, et al.
Molecular Carcinogenesis|February 23, 2017
Loss of MLH1 sensitizes colon cancer cells to DNA-PKcs inhibitor KU60648Inga Hinrichsen, Anne Ackermann, Tonja Düding, et al.
Human Mutation|April 5, 2012
MUTYH gene expression and alternative splicing in controls and polyposis patientsGuido Plotz, Markus Casper, Jochen Raedle, et al.
Cancers|July 24, 2021
SPTAN1 Expression Predicts Treatment and Survival Outcomes in Colorectal CancerChristopher Schrecker, Sophia Behrens, Rebecca Schönherr, et al.
Molecular Carcinogenesis|August 3, 2017
Phosphorylation-dependent signaling controls degradation of DNA mismatch repair protein PMS2Inga Hinrichsen, Isabel M Weßbecher, Meik Huhn, et al.
Gastroenterology|January 10, 2002
Functional analysis of hMLH1 variants and HNPCC-related mutations using a human expression systemJoerg Trojan, Stefan Zeuzem, Ann Randolph, et al.
Cancer|July 15, 2005
BRAF mutations in colorectal carcinoma suggest two entities of microsatellite-unstable tumorsNikolaus Lubomierski, Guido Plotz, Marc Wormek, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 4, 2009
An interstitial deletion at 3p21.3 results in the genetic fusion of MLH1 and ITGA9 in a Lynch syndrome familyClaus Meyer, Angela Brieger, Guido Plotz, et al.
Pageof 5